While robots have proven effective in enhancing the precision and time efficiency of MRI-guided interventions across various medical applications, safety remains a formidable challenge for robots operating within MRI environments. As the robots assume full control of medical procedures, the reliability of their operation becomes paramount. Precise control over robot forces is particularly crucial to ensure safe interaction within the MRI environment. Furthermore, the confined space in the MRI bore complicates the safe operation of human-robot interaction, presenting challenges to maneuverability. However, there exists a notable scarcity of force-controlled robot actuators specifically tailored for MRI applications.       To overcome these challenges, UC Berkeley researchers have developed a novel MRI-compatible rotary series elastic actuator module utilizing velocity-sourced ultrasonic motors for force-controlled robots operating within MRI scanners. Unlike previous MRI-compatible SEA designs, the module incorporates a transmission force sensing series elastic actuator structure, while remaining compact in size. The actuator is cylindrical in shape with a length shorter than its diameter and integrates seamlessly with a disk-shaped motor. A precision torque controller enhances the robustness of the invention’s torque control even in the presence of varying external impedance; the torque control performance has been experimentally validated in both 3 Tesla MRI and non-MRI environments, achieving a settling time of 0.1 seconds and a steady-state error within 2% of its maximum output torque. It exhibits consistent performance across low and high external impedance scenarios, compared to conventional controllers for velocity-sourced SEAs that struggle with steady-state performance under low external impedance conditions.

An innovative technique to produce dissolvable calcium alginate microfibers using an immersed microfluidic spinning process for creating tissue constructs and vascularized tissue implants.

Researchers at the University of California, Davis have developed an approach to elicit powerful immune responses by engineering the binding capabilities of single chain trimer (SCT) proteins to CD8.

Researchers at the University of California, Davis have discovered an Arthrobacter bacterial strain that promotes suberization of the endodermis in sorghum roots. Suberin, a poly-fatty acid polymer, acts as a physical barrier in sorghum roots, helping to prevent infection by the parasitic plant Striga hermonthica, a significant threat to sorghum production. These microbial-based solutions offer a cost-effective and easily deployable strategy to manage Striga infection in the predominantly smallholder farmer-driven sorghum cultivation of sub-Saharan Africa.

      Quantum sensing is rapidly reshaping our ability to discern chemical processes with high sensitivity and spatial resolution. Many quantum sensors are based on nitrogen-vacancy (NV) centers in diamond, with nanodiamonds (NDs) providing a promising approach to chemical quantum sensing compared to single crystals for benefits in cost, deployability, and facile integration with the analyte. However, high-precision chemical quantum sensing suffers from large statistical errors from particle heterogeneity, fluorescence fluctuations related to particle orientation, and other unresolved challenges.      To overcome these obstacles, UC Berkeley researchers have developed a novel microfluidic chemical quantum sensing device capable of high-precision, background-free quantum sensing at high-throughput. The microfluidic device solves problems with heterogeneity while simultaneously ensuring close interaction with the analyte. The device further yields exceptional measurement stability, which has been demonstrated over >103s measurement and across ~105 droplets.  Greatly surpassing the stability seen in conventional quantum sensing experiments, these properties are also resistant to experimental variations and temperature shifts. Finally, the required ND sensor volumes are minuscule, costing only about $0.63 for an hour of analysis. 

Cell culture plates are an essential tool for cell biology research. They are used to grow cells in a controlled environment, which allows for study of the effects of different conditions on cell growth and development. The plates are typically made of plastic or glass and may have one or more wells, each of which can hold a small amount of cell culture media. The media provides the cells with the nutrients the cells need to grow and divide. Cell culture plates may be used in incubators to grow cells in a controlled environment as well as in glove boxes. The incubator provides the cells with the necessary conditions for growth, including a constant temperature, humidity, and atmosphere.Conventional cell culture plates are susceptible to evaporation, which causes increased osmolarity of cell culture media. This in turn causes unnatural growth of cells and well-to-well variability due to uneven evaporation. In addition, evaporation causes increased concentration of the salts involved in electrical signaling of electrically active cell types, changing the ionic gradients across the cell membrane, and affecting all characteristics of the initiation, transmission (and computation) in electrically active cells such as cardiac or neuronal cells. It is also difficult to maintain desired dissolved gas concentration with standard cell culture plates. This generally requires use of a compressed gas system, which uses gas regulators, sensors that are expensive and have limited lifetimes, and feedback control as well as a glove box for culture and/or handling.An incubator is used to maintain the desired temperature of the cell culture plates. The incubator impedes access to the cultures for feeding, for microscopy, etc. Furthermore, observation equipment for use inside an incubator needs to be designed to resist incubator conditions (e.g., body temperature heat and humidity). Incubators also take up significant space and packing of incubators in a laboratory is space-inefficient relative to the form factor of the cell culture plates. As the number of cell culture plates in a single incubator increases, the ability of the incubator to perform its function decreases, since there is a minimum number of times an incubator may be accessed per week per cell culture vessel. However, every time the incubator is accessed, it is unable to perform its functions for a prolonged period of time, e.g., over 30 minutes. Another technical problem is that cell culture devices that use an air gap for gas exchange have an increased risk of microbial contamination via that air gap. This makes it difficult to perform manual cell culture experiments over the course of months without contamination. In addition, cross-contamination is more likely if multiple different experiments are being performed in the same laboratory. Thus, there is a need for cell culture vessels and systems that overcome these problems.

Researchers at the University of California, Davis have developed a technology providing the creation of stable analogs of glycosphingosines and gangliosides containing O-acetylated sialic acid for extensive biological and medical applications.

The invention presents a microfluidic platform equipped with specialized trapping arrays and droplet generation capabilities, enabling precise control over the formation of microvortices within cell-laden droplets. This novel system facilitates the study of cell-cell interactions at a single-cell level, offering configurable microenvironments for analyzing cell dynamics and pair relationships.

An innovative sulfoxide-containing MS-cleavable cross-linker, DBrASO, specifically designed for cysteine residues and aimed at enhancing protein-protein interactions studies and protein complexes architecture analysis.

An innovative mass spectrometry platform that utilizes sulfoxide-containing MS-cleavable heterobifunctional photoactivated cross-linkers to enhance protein structural elucidation.

A breakthrough technology using insulin-secreting cells and stem cells to enhance wound healing and reduce scar formation.

A novel method and device for high-throughput sorting of cells in suspension, particularly focusing on the separation of key cellular blood components of the immune system. The patent application presents a novel approach to high-throughput cell sorting, particularly suitable for applications in medicine and biotechnology where precise separation of cell populations is crucial.

A design for compact and energy-efficient microvalves for use in lab-on-a-chip microfluidic devices

Researchers at the University of California, Davis have developed an innovative method for efficient, high-yield production and easy purification of Human Milk Oligosaccharides (HMOs) using a Multistep One-Pot Multienzyme (MSOPME) process.

Researchers at the University of California, Davis have developed a method for preparing a glycan product containing a nonulosonic acid moiety by means of legionaminic acid transferase fusion proteins

Brief description not available

Brief description not available

Brief description not available

In cells, DNA is organized by wrapping DNA strands around histone proteins, creating protein-DNA complexes called nucleosomes which comprise the basic unit of chromatin. Chromatin is associated with regions of low gene expression, as compacted DNA is inaccessible to proteins that would promote transcription. Conversely, regions in the DNA not bound by histones experience higher gene expression, as this DNA is readily available to be transcribed.  Nucleosomes are not uniformly positioned on a DNA molecule, and they change based on factors like which genes are expressed during different cellular processes. It is beneficial to understand where nucleosomes are positioned, as this can provide insight into how genes are regulated, or how factors like epigenetic modifications or chromatin structure affect this accessibility and can additionally illuminate gene expression patterns in disease for designing therapies. Nucleosome profiling is a technique used to study the positions of nucleosomes along a DNA molecule. Typically, histones are crosslinked to DNA, then the DNA is fragmented and digested leaving only regions protected by nucleosomes left for short-read sequencing. However, this fragmentation only reveals nucleosome positioning at the resolution of a few hundred base pairs, leaving the larger genomic context of these nucleosome positions to be desired. To address this, researchers at UC Santa Cruz developed Add-SEQ, a pipeline using long-read nanopore sequencing to map nucleosomes across long stretches > 10 kb of single DNA molecules.

This invention overcomes a limitation of in vivo mutagenesis systems. Some methods of mutagenesis involve treatment of plasmids with mutagenic chemicals or UV light prior to transformation, but these result in biased mutation spectra. Use of error prone DNA polymerases produces a more random set of mutations, but the rate of mutagenesis rapidly declines with continuous culture. As a result, using such polymerasaes separates mutagenesis and selection into multiple steps. Mutant genes in plasmids need to be generated by the error prone polymerase, then the plasmids isolated into libraries and selected in a separate step. What is needed, then is an error prone DNA polymerase that does not result in a decline in the rate of mutagenesis in culture.  

An abasic site (i.e., an apurinic or apyrimidinic site) in a DNA or RNA strand is one in which the base is not present, but the sugar phosphate backbone remains intact. UC Santa Cruz researchers discovered that nanopore sequencers can readily detect the positions of abasic sites within a DNA strand during sequencing. This invention capitalizes on this discovery by using enzymes to generate abasic sites at places on a DNA strand that contain modified bases. The DNA strand can then be sequenced using nanopore sequencing, thereby providing a way of detecting modified bases.

Brief description not available

Cardiovascular disease is the leading cause of death both worldwide and in the United States, with associated costs in the U.S. reaching approximately $229 billion, each, in 2017 and 2018. Early detection, which can drastically reduce both rates of death and treatment costs, requires access to facilities and highly-trained physicians that can be difficult to access in rural areas and developing countries—despite their prevalence of cardiovascular disease. Computer-based models that use, e.g., PCG (phonocardiogram), EKG (electrocardiogram), or other cardiac data, are a promising route to bridge the gap in standard-of-care for these underserved areas. However, current algorithms are unable to account for demographic features, such as race, sex, or other characteristics, which are known to affect both the structure of the heart and presentation of heart disease. To address this problem, UC Berkeley researchers have developed a new, cloud-based system for collecting a patient's continuous cardiovascular data, monitoring for and detecting disease, and keeping a doctor informed about the cardiac health of the patient. The system sends an alarm when disease or heart attack are detected. To generate the most accurate diagnoses by taking into account demographic information, the system includes private and ethical dataset collection and model-training techniques.

Plasma medicine has emerged as a promising approach for treatment of biofilm-related and virus infections, assistance in cancer treatment, and treatment of wounds and skin diseases. However, an important challenge arises with the need to adapt control policies, often only determined after each treatment and using limited observations of therapeutic effects. Control policy adaptation that accounts for the variable characteristics of plasma and of target surfaces across different subjects and treatment scenarios is needed. Personalized, point-of-care plasma medicine can only advance efficaciously with new control policy strategies.To address this opportunity, UC Berkeley researchers have developed a novel control scheme for tailored and personalized plasma treatment of surfaces. The approach draws from concepts in deep learning, Bayesian optimization and embedded control. The approach has been demonstrated in experiments on a cold atmospheric plasma jet, with prototypical applications in plasma medicine.

Plastics are essential for the modern world but are also non-sustainable products of the petrochemical industry that negatively impact our health, environment, and food chain. Natural biogenic plastics, such as polyhydroxyalkanoates (PHA), are readily biodegradable, can be produced more sustainably, and offer an attractive alternative. The global demand for bioplastics is increasing with the 2019 market value of $8.3B expected to reach a compound annual growth rate of 16.1% from 2020-2027 (https://www.grandviewresearch.com/industry-analysis/bioplastics-industry). However, current PHA production is constrained by the underlying physiology of the microorganisms which produce them, meaning bioplastic production is currently limited to inefficient, batch fermentation processes that are difficult to scale.To address this problem, UC Berkeley researchers have developed a new system for PHA production wherein the PHA are generated continuously throughout microorganism growth lifecycles. The invention allows these sustainable bioplastics to be produced via precision continuous fermentation technology, a scalable and efficient approach.